Akanda (AKAN) Competitors $3.29 -0.06 (-1.79%) Closing price 04:00 PM EasternExtended Trading$3.34 +0.04 (+1.37%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock AKAN vs. PMCB, PLRZ, ARTL, LIAN, ENSC, VIVS, PALI, NKGN, SXTP, and BCTXShould you be buying Akanda stock or one of its competitors? The main competitors of Akanda include Nuvilex (PMCB), Polyrizon (PLRZ), Artelo Biosciences (ARTL), LianBio (LIAN), Ensysce Biosciences (ENSC), VivoSim Labs (VIVS), Palisade Bio (PALI), NKGen Biotech (NKGN), 60 Degrees Pharmaceuticals (SXTP), and Briacell Therap (BCTX). These companies are all part of the "pharmaceutical products" industry. Akanda vs. Its Competitors Nuvilex Polyrizon Artelo Biosciences LianBio Ensysce Biosciences VivoSim Labs Palisade Bio NKGen Biotech 60 Degrees Pharmaceuticals Briacell Therap Nuvilex (NASDAQ:PMCB) and Akanda (NASDAQ:AKAN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Does the media refer more to PMCB or AKAN? In the previous week, Akanda had 1 more articles in the media than Nuvilex. MarketBeat recorded 1 mentions for Akanda and 0 mentions for Nuvilex. Nuvilex's average media sentiment score of 0.00 beat Akanda's score of -1.00 indicating that Nuvilex is being referred to more favorably in the media. Company Overall Sentiment Nuvilex Neutral Akanda Negative Is PMCB or AKAN more profitable? Nuvilex's return on equity of 4.60% beat Akanda's return on equity.Company Net Margins Return on Equity Return on Assets NuvilexN/A 4.60% 3.76% Akanda N/A N/A N/A Which has more volatility & risk, PMCB or AKAN? Nuvilex has a beta of -0.24, indicating that its share price is 124% less volatile than the S&P 500. Comparatively, Akanda has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Do insiders and institutionals have more ownership in PMCB or AKAN? 34.2% of Nuvilex shares are held by institutional investors. Comparatively, 1.0% of Akanda shares are held by institutional investors. 10.2% of Nuvilex shares are held by company insiders. Comparatively, 20.4% of Akanda shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has preferable earnings and valuation, PMCB or AKAN? Nuvilex has higher earnings, but lower revenue than Akanda. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuvilexN/AN/A$30.66M$2.590.41Akanda$840K1.80-$4.10MN/AN/A SummaryNuvilex beats Akanda on 5 of the 9 factors compared between the two stocks. Get Akanda News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AKAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKAN vs. The Competition Export to ExcelMetricAkandaMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.53M$11.07B$5.81B$10.01BDividend YieldN/A1.84%5.29%4.53%P/E RatioN/A21.9375.6926.28Price / Sales1.8031.47539.36121.13Price / CashN/A24.6337.2059.76Price / Book0.353.5811.506.41Net Income-$4.10M$212.34M$3.28B$270.56M7 Day Performance-6.53%-0.88%1.30%3.01%1 Month Performance-10.78%16.26%11.25%9.74%1 Year Performance-52.15%-7.08%59.54%26.68% Akanda Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKANAkanda0.6188 of 5 stars$3.29-1.8%N/A-51.3%$1.53M$840K0.00110Negative NewsShort Interest ↑PMCBNuvilex0.4507 of 5 stars$0.95+0.6%N/A-28.9%$6.43MN/A0.364Upcoming EarningsGap DownHigh Trading VolumePLRZPolyrizonN/A$1.07-1.8%N/AN/A$6.41MN/A0.00N/APositive NewsARTLArtelo Biosciences2.8624 of 5 stars$9.05-2.2%$24.00+165.2%-36.8%$6.34MN/A-0.485Analyst ForecastShort Interest ↑LIANLianBioN/A$0.06+1.4%N/A-82.2%$6.21MN/A-0.07110ENSCEnsysce Biosciences0.1613 of 5 stars$2.08-0.5%N/A-62.6%$6.17MN/A-0.5210Positive NewsVIVSVivoSim LabsN/A$2.34-4.1%N/AN/A$6.08M$140K-0.2320PALIPalisade Bio2.5448 of 5 stars$0.66-2.0%$12.00+1,712.7%-84.1%$6.04MN/A-0.1610NKGNNKGen Biotech0.1808 of 5 stars$0.13flatN/A-80.8%$5.96MN/A-0.03N/ANews CoverageSXTP60 Degrees Pharmaceuticals2.0721 of 5 stars$1.42+0.7%$7.00+393.0%-79.6%$5.82M$300K-0.033BCTXBriacell Therap2.0999 of 5 stars$8.47+9.0%$320.00+3,678.0%-92.7%$5.74MN/A-0.108 Related Companies and Tools Related Companies PMCB Competitors PLRZ Competitors ARTL Competitors LIAN Competitors ENSC Competitors VIVS Competitors PALI Competitors NKGN Competitors SXTP Competitors BCTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AKAN) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akanda Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akanda With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKAN Stock Alerts